Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 11/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 8/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 6/20 | 1.00 |
| ▸ | LMNA | P02545 | 5/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 5/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 5/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 5/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 3/20 | 1.00 |
| ▸ | TSHR | P16473 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | NR1I2 | O75469 | 4/20 | 0.71 |
| ▸ | NR3C1 | P04150 | 4/20 | 0.71 |
| ▸ | CYP17A1 | P05093 | 4/20 | 0.71 |
| ▸ | PGR | P06401 | 4/20 | 0.71 |
| ▸ | ADRB1 | P08588 | 4/20 | 0.71 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.71 |
| ▸ | DRD2 | P14416 | 4/20 | 0.71 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.71 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Enilconazole SCHEMBL8817070 | 1.00 | IDO1 (1.00) | IDO1CYP2C9CYP3A4LMNACYP1A2 | |
| Enilconazole SCHEMBL29394655 | 1.00 | IDO1 (1.00) | IDO1CYP2C9CYP3A4LMNACYP1A2 | |
| Enilconazole SCHEMBL22498 | 1.00 | IDO1 (1.00) | IDO1CYP2C9CYP3A4LMNACYP1A2 | |
| Enilconazole SCHEMBL29608451 | 1.00 | IDO1 (1.00) | IDO1CYP2C9CYP3A4LMNACYP1A2 | |
| Enilconazole SCHEMBL7913333 | 1.00 | IDO1 (1.00) | IDO1CYP2C9CYP3A4LMNACYP1A2 | |
| Enilconazole SCHEMBL28210284 | 0.97 | IDO1 (0.93) | IDO1CYP2C9CYP3A4LMNACYP1A2 | |
| Enilconazole SCHEMBL3913478 | 0.96 | IDO1 (0.91) | IDO1CYP2C9CYP3A4LMNACYP1A2 | |
| Enilconazole SCHEMBL15756772 | 0.94 | LMNA (1.00) | IDO1CYP2C9CYP3A4LMNACYP1A2 | |
| Enilconazole SCHEMBL41653 | 0.94 | LMNA (1.00) | IDO1CYP2C9CYP3A4LMNACYP1A2 | |
| Enilconazole SCHEMBL15757117 | 0.94 | LMNA (1.00) | IDO1CYP2C9CYP3A4LMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240065267-A1 | PLANT DISEASE CONTROL COMPOSITION AND METHOD FOR CONTROLLING PLANT DISEASE BY APPLYING THE SAME | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2024-02-29 | — | — | US | claimed |
| CN-115028586-A | Preparation method of chiral (S) -imazalil | 池州中瑞化工有限公司 | 2022-09-09 | — | — | CN | claimed |
| WO-2018148224-A1 | PHOSPHOLIPID ETHER (PLE) CAR T CELL TUMOR TARGETING (CTCT) AGENTS | Seattle Children's Hospital (dba Seattle Children's Research Institute) (US) | 2018-08-16 | — | — | WO | claimed |
| US-12310365-B2 | Plant disease control composition and method for controlling plant disease by applying the same | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2025-05-27 | — | — | US | disclosed |
| US-20240065267-A1 | PLANT DISEASE CONTROL COMPOSITION AND METHOD FOR CONTROLLING PLANT DISEASE BY APPLYING THE SAME | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2024-02-29 | — | — | US | disclosed |
| US-11805779-B2 | Plant disease control composition and method for controlling plant disease by applying the same | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2023-11-07 | — | — | US | disclosed |
| CN-115028586-A | Preparation method of chiral (S) -imazalil | 池州中瑞化工有限公司 | 2022-09-09 | — | — | CN | disclosed |
| CN-115028586-A | Preparation method of chiral (S) -imazalil | 池州中瑞化工有限公司 | 2022-09-09 | — | — | CN | disclosed |
| CN-115028586-A | Preparation method of chiral (S) -imazalil | 池州中瑞化工有限公司 | 2022-09-09 | — | — | CN | disclosed |
| WO-2018148224-A1 | PHOSPHOLIPID ETHER (PLE) CAR T CELL TUMOR TARGETING (CTCT) AGENTS | Seattle Children's Hospital (dba Seattle Children's Research Institute) (US) | 2018-08-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240065267-A1 | PLANT DISEASE CONTROL COMPOSITION AND METHOD FOR CONTROLLING PLANT DISEASE BY APPLYING THE SAME | SNX1, HAX1, BROX | IDO1 1188/4885CYP2C9 2765/4885CYP3A4 2379/4885 |
| US-12310365-B2 | Plant disease control composition and method for controlling plant disease by applying the same | SNX1, HAX1, BROX | IDO1 1188/4885CYP2C9 2765/4885CYP3A4 2379/4885 |
| US-11805779-B2 | Plant disease control composition and method for controlling plant disease by applying the same | SNX1, HAX1, BROX | IDO1 1188/4885CYP2C9 2765/4885CYP3A4 2379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.